Reduced tyrosine phosphorylation and nonresponsiveness to EGF-mediated cytotoxicity in EGF receptor-hyperproducing UCVA-1 cells.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Cellular Signalling

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0898-6568(90)90052-CPMID 2169292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor

  1989cited by this paper
• Role of phosphatidylinositol kinase in PDGF receptor signal transduction.

  1989cited by this paper
• Stimulation of a Mr 80,000 protein phosphorylation by EGF in EGF receptor‐hyperproducing human tumor cells

  1989cited by this paper
• Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

  1989cited by this paper
• Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium.

  1989cited by this paper
• EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.

  1989cited by this paper
• Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro

  1989cited by this paper
• A point mutation at the ATP‐binding site of the EGF‐receptor abolishes signal transduction.

  1988cited by this paper
• Phosphorylation of cellular proteins in Rous sarcoma virus-infected cells: analysis by use of anti-phosphotyrosine antibodies

  1988cited by this paper
• Two independent mechanisms for escaping epidermal growth factor- mediated growth inhibition in epidermal growth factor receptor- hyperproducing human tumor cells

  1988cited by this paper
• Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.

  1988cited by this paper
• Change in metabolic turnover is an alternate mechanism increasing cell surface epidermal growth factor receptor levels in tumor cells.

  1987cited by this paper
• Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor

  1987cited by this paper
• Tyrosine phosphorylation of common and specific sets of cellular proteins rapidly induced by insulin, insulin-like growth factor I, and epidermal growth factor in an intact cell.

  1987cited by this paper
• Protein kinase C-stimulated phosphorylation in vitro of a Mr 80,000 protein phosphorylated in response to phorbol esters and growth factors in intact fibroblasts. Distinction from protein kinase C and prominence in brain.

  1986cited by this paper
• Down regulation of phorbol diester receptors by proteolytic degradation of protein kinase C in a cultured cell line of fetal rat skin keratinocytes.

  1986cited by this paper
• EGF receptor affinity is regulated by intracellular calcium and protein kinase C.

  1985cited by this paper
• Characterization of distinct tyrosine-specific protein kinases in B and T lymphocytes.

  1985cited by this paper
• Separation and characterization of a phosphatidylinositol kinase activity that co-purifies with the epidermal growth factor receptor.

  1985cited by this paper
• Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, possessing high numbers of EGF receptors.

  1984cited by this paper
• Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor

  1984cited by this paper
• Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells.

  1984cited by this paper
• Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF.

  1982cited by this paper
• Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes.

  1980cited by this paper
• Characterization of Rous sarcoma virus src gene products synthesized in vitro

  1978cited by this paper
• High resolution two-dimensional electrophoresis of proteins.

  1975cited by this paper

• Cinnamtannin D-1 protects pancreatic β-cells from palmitic acid-induced apoptosis by attenuating oxidative stress.

  2014cites this paper
• Interruption of NFkappaB-STAT1 signaling mediates EGF-induced cell-cycle arrest.

  2000cites this paper
• Interruption of NFκb–stat1 signaling mediates EGF‐induced cell‐cycle arrest

  2000cites this paper
• Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell-cycle arrest in A431 cells

  1998cites this paper
• Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells.

  1998cites this paper
• Light-dependent induction of early-response gene expression by calphostin-C.

  1994cites this paper
• Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.

  1994cites this paper
• Calphostin‐C stimulates epidermal growth factor receptor phosphorylation and internalization via light‐dependent mechanism

  1994cites this paper